TORONTO, Oct 6, 2021 (GLOBE NEWSWIRE) – VitalHub Corp. (the “Company” or “VitalHub”) (TSX: VHI) today announced that Harrogate and District NHS Foundation Trust (the “Trust” or “Harrogate and District”) has authorized VitalHub’s Solution to Make Appropriate Patient Care (MCAP) to be implemented within the Trust’s 300-bed district general hospital. This is a 2 year product license with an option to extend for an additional 2 years.
The Trust has secured the Making Care Appropriate for Patients (MCAP) product for use in the 300 beds at Harrogate and District General Hospital. Harrogate and District plans to use MCAP’s intuitive patient flow solution to identify an increased number of patients who can be safely transferred to lower levels of care to improve overall patient flow. The Trust aims to prioritize resources in order to close the national backlog resulting from patient flow issues during the COVID-19 pandemic and to reduce pressure on their elective care pathways.
MCAP will be used to identify opportunities for improving and integrating patient flow across the system, providing decision makers with the evidence needed to enable advanced real-time patient flow analysis to support improvements in patient flow. the exit of multidisciplinary teams and system integration.
“We are proud to have multiple MCAP implementations in the UK, Qatar and Australia, and we are encouraged by the continued success of this product,” said Dan Matlow, CEO of VitalHub Corp. “The growth of our existing contract with Harrogate and District NHS Foundation Trust demonstrates the trust our customers place in us to provide cutting-edge solutions to power their operations. This is a good example of the strong organic growth of the company, thanks to consistent value across our existing installation base. “
This is the second license transaction between VitalHub and Harrogate and District NHS Foundation Trust this year. In March 2021, VitalHub announced the licensing by the Trust to VitalHub’s subsidiary, Intouch with Health, the digital health platform.
Issue of stock options
In addition to the product license agreement with the Trust, VitalHub also announced today the granting of incentive stock options as compensation to certain of its employees and consultants.
Options to purchase a maximum of 50,000 common shares (the “Shares”) of the Company were granted at an exercise price of $ 2.85 per share, in accordance with the terms of the Option Plan.
ABOUT THE NHS HARROGATE AND DISTRICT FOUNDATION TRUST: Harrogate and District NHS Foundation Trust cares for the people of Harrogate and the region, as well as North Yorkshire and Leeds. We also provide children’s services in the main part of the North East in County Durham, Darlington, Middlesbrough, Stockton-on-Tees, Gateshead and Sunderland. Harrogate and District NHS Foundation Trust employs over 4,000 people, caring for a wide range of people providing essential hospital treatment as well as community health services.
ABOUT VITALHUB: Software for health and social service providers designed to simplify user experience and optimize results.
VitalHub provides technology to health and social service providers, including; Hospitals, regional health authorities, mental health, long-term care, home care, community and social services. VitalHub solutions cover the categories of electronic health record (EHR), case management, care coordination, patient flow and operational visibility and DOCit mobile applications.
The Company has a strong two-pronged growth strategy, targeting organic growth opportunities within its product line and pursuing an aggressive M&A plan. Currently, VitalHub serves 400 customers across Canada, United States, United Kingdom, Australia, Qatar and Latvia. VitalHub is based in Toronto, Canada, with an offshore development center in Sri Lanka. The Company is listed on the Toronto Stock Exchange under the symbol “VHI”.
CAUTION : This press release includes forward-looking statements regarding the Company and its business, which may include, without limitation, statements regarding the appointment of new directors. Often, but not always, forward-looking statements can be identified by the use of words such as “plans”, “is expected”, “expects”, “planned”, “is considering”, “is considering”, “is planning”. “,” Believes “,” proposes “or variations (including negative variations) of these words and expressions, or declares that certain actions, events or results” could “,” could “,” would “,” could “or “will” be undertaken, occur or be achieved. These statements are based on the current expectations of the management of each entity and are based on assumptions and subject to risks and uncertainties. Although the management of each entity believes that the assumptions underlying these statements are reasonable, they may prove to be inaccurate. The forward-looking events and circumstances described in this press release may not occur on certain specified dates or may not occur at all and could differ materially in ra ison of known and unknown risk factors and uncertainties affecting companies, including risks regarding the technology industry, failure to obtain regulatory or shareholder approvals, market conditions, economic factors, current stock markets. general and the risks associated with growth and competition. Although the Company has attempted to identify material factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or or results differ from those anticipated, estimated or intended. No forward-looking statement can be guaranteed. Except as required by applicable securities laws, forward-looking statements speak only as of the date on which they are made and the Company assumes no obligation to publicly update or revise any forward-looking statement, whether whether as a result of new information, future events, or otherwise.
Chairman and CEO, Director